Background: Antimicrobial overprescribing contributes to bacterial resistan
ce, but data on use in infants and young children are limited.
Objectives: To assess antimicrobial use in a defined population of infants
and young children and to determine diagnosis-specific prescribing rates fo
r common infections.
Design and Setting: Retrospective cohort study of children served by 44 pra
ctices affiliated with 2 managed care organizations.
Patients: Children aged 3 months to 72 months enrolled in either health pla
n between September 1, 1994, and August 31, 1996.
Analysis: Rates of antimicrobial use were calculated as the number of pharm
acy dispensings divided by the number of person-years of observation contri
buted to the cohort in 2 age groups (3 to <36 months and 36 to <72 months).
Other outcomes included the distribution of diagnoses associated with anti
microbial dispensing and population-based rates of diagnosis of common acut
e respiratory tract illnesses.
Results: A total of 46 477 children contributed 59 710 person-years of obse
rvation across the 2 health plans. Rates of antimicrobial dispensing for ch
ildren aged 3 to 36 months were 3.2 and 2.1 dispensings per person-year in
the 2 populations. A substantial fraction of younger children (35% in popul
ation A and 23% in population B) received 4 or more antimicrobial prescript
ions in a single year. For children aged 36 to 72 months, the dispensing ra
tes for the 2 populations were 2.0 and 1.5 antimicrobials per person-year.
We found significant differences in rates between the populations studied a
nd a decrease in use at all sites from 1995 to 1996. The diagnosis of otiti
s media accounted for 56% of antimicrobial drugs dispensed to children aged
3 to 36 months and 40% of those dispensed to children aged 36 to 72 months
. Antimicrobial prescribing for colds and upper respiratory tract infection
s, bronchitis, and sinusitis was less frequent than previously reported but
accounted for 10% to 14% of antimicrobial drugs dispensed.
Conclusions: In these populations, otitis media accounted for the largest n
umber of antimicrobial agents dispensed to children younger than 6 years. C
learly inappropriate indications such as cold, upper respiratory tract infe
ction, and bronchitis accounted for smaller fractions of antimicrobial use
but may be most amenable to change. However, interventions that encourage u
se of strict criteria for diagnosis and treatment of otitis media will like
ly have the greatest impact on overall antimicrobial exposure. Monitoring d
efined populations longitudinally will allow assessment of the effectivenes
s of such national and local initiatives.